Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 16, 2022; 10(32): 11726-11742
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11726
Figure 4
Figure 4 Receiver operating characteristic curves of the nomograms and tumor-node-metastasis staging system for overall survival and cancer-specific survival in patients with squamous cell carcinoma of the tongue. A: Receiver operating characteristic curves (ROC) for 3-year overall survival (OS) in the training cohort; B: ROC for 5-year OS in the training cohort; C: ROC for 3-year OS in the validation cohort; D: ROC for 5-year OS in the validation cohort; E: ROC for 3-year cancer-specific survival (CSS) in the training cohort; F: ROC for 5-year CSS in the training cohort; G: ROC for 3-year CSS in the validation cohort; H: ROC for 5-year CSS in the validation cohort. TNM: Tumor-node-metastasis.